Literature DB >> 9150474

Renal TGF-beta in HIV-associated kidney diseases.

I Bódi1, P L Kimmel, A A Abraham, L P Svetkey, P E Klotman, J B Kopp.   

Abstract

Human immunodeficiency virus (HIV)-1 infection may be complicated by progressive renal glomerular disease, including focal segmental glomerulosclerosis (FSGS) and proliferative glomerulonephritis. We examined renal tissue from 71 patients, including biopsies and autopsies from patients in the presence and absence of HIV-1 infection. We assessed the extent of TGF-beta, interstitial fibrosis, and interstitial CD45-positive cellular infiltrate using immunohistochemistry. Extracellular TGF-beta 1/beta 3 was largely confined to the renal interstitium, with the highest scores in HIV-seropositive renal disease and crescentic nephritis. Among all biopsies, the TGF-beta 1/beta 3 score correlated with the fibrosis score (r = 0.79, P < 0.0001) and with the CD45 score (r = 0.60, P < 0.0001). Biopsies from HIV-infected patients, taken together, showed marginally more TGF-beta 1/beta 3 compared to biopsies from HIV-uninfected patients (P = 0.05); similarly, HIV-associated FSGS showed marginally more TGF-beta 1/beta 3 compared to FSGS biopsies obtained from HIV-uninfected patients (P = 0.05). Intracellular TGF-beta 1 and TGF-beta 3 were both expressed by renal tubular epithelial cells and in extraglomerular crescents, whereas TGF-beta 3 was also present within interstitial mononuclear cells and eosinophils, and, exclusively in HIV-infected patients, within glomerular cells. In conclusion, TGF-beta expression was increased in several progressive glomerular diseases, and was particularly but not uniquely elevated in HIV-associated renal diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150474     DOI: 10.1038/ki.1997.215

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  The functionality of African-specific variants in the TGFB1 regulatory region and their potential role in HIVAN.

Authors:  M Nel; J-M Buys; F C J Botha; N Wearne; S Prince; J M Heckmann
Journal:  Clin Exp Nephrol       Date:  2017-12-04       Impact factor: 2.801

Review 2.  HIV-associated renal disorders: recent insights into pathogenesis and treatment.

Authors:  Ruth Berggren; Vecihi Batuman
Journal:  Curr HIV/AIDS Rep       Date:  2005-08       Impact factor: 5.071

3.  TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.

Authors:  Toru Sakairi; Yoshifusa Abe; Jeffrey B Kopp
Journal:  Nephrol Dial Transplant       Date:  2011-03-04       Impact factor: 5.992

4.  Regenerative potential of platelets in patients with chronic kidney disease.

Authors:  Elżbieta Cecerska-Heryć; Rafał Heryć; Magda Wiśniewska; Anna Michalczyk; Barbara Dołęgowska
Journal:  Int Urol Nephrol       Date:  2019-06-13       Impact factor: 2.370

5.  Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Katarzyna Taranta-Janusz
Journal:  Pediatr Nephrol       Date:  2008-12-02       Impact factor: 3.714

6.  Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy.

Authors:  Leyi Gu; Yan Dai; Jin Xu; Sandeep Mallipattu; Lewis Kaufman; Paul E Klotman; John C He; Peter Y Chuang
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

Review 7.  A 20-year history of childhood HIV-associated nephropathy.

Authors:  Patricio E Ray; Lian Xu; Tamara Rakusan; Xue-Hui Liu
Journal:  Pediatr Nephrol       Date:  2004-08-05       Impact factor: 3.714

Review 8.  Infection and glomerulonephritis.

Authors:  Saraladevi Naicker; June Fabian; Sagren Naidoo; Shoyab Wadee; Graham Paget; Stewart Goetsch
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

9.  Higher plasma transforming growth factor (TGF)-β is associated with kidney disease in older community dwelling adults.

Authors:  Tapan Mehta; Petra Buzkova; Jorge R Kizer; Luc Djousse; Michel Chonchol; Kenneth J Mukamal; Michael Shlipak; Joachim H Ix; Diana Jalal
Journal:  BMC Nephrol       Date:  2017-03-21       Impact factor: 2.388

Review 10.  The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders.

Authors:  Annette J Theron; Ronald Anderson; Theresa M Rossouw; Helen C Steel
Journal:  Front Immunol       Date:  2017-11-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.